Home/Filings/4/0001628280-24-010752
4//SEC Filing

Richardson Garrie 4

Accession 0001628280-24-010752

CIK 0000834365other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 9:45 PM ET

Size

5.1 KB

Accession

0001628280-24-010752

Insider Transaction Report

Form 4
Period: 2024-03-08
Richardson Garrie
Chief Revenue Officer
Transactions
  • Award

    Common Stock

    2024-03-08+12,516117,843 total
Footnotes (1)
  • [F1]The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2024 compensation.

Issuer

BIOLIFE SOLUTIONS INC

CIK 0000834365

Entity typeother

Related Parties

1
  • filerCIK 0001999183

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 9:45 PM ET
Size
5.1 KB